0001209191-16-153908.txt : 20161207 0001209191-16-153908.hdr.sgml : 20161207 20161207163546 ACCESSION NUMBER: 0001209191-16-153908 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161206 FILED AS OF DATE: 20161207 DATE AS OF CHANGE: 20161207 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Intra-Cellular Therapies, Inc. CENTRAL INDEX KEY: 0001567514 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 364742850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 212-923-3344 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET CITY: NEW YORK STATE: NY ZIP: 10016 FORMER COMPANY: FORMER CONFORMED NAME: Oneida Resources Corp. DATE OF NAME CHANGE: 20130122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALAFI MOSHE CENTRAL INDEX KEY: 0001008890 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36274 FILM NUMBER: 162039415 MAIL ADDRESS: STREET 1: 1311 ORLEANS DRIVE CITY: SUNNYVALE STATE: CA ZIP: 94089 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-12-06 0 0001567514 Intra-Cellular Therapies, Inc. ITCI 0001008890 ALAFI MOSHE C/O ALAFI CAPITAL COMPANY, LLC 8 ADMIRAL DRIVE, SUITE 324 EMERYVILLE CA 94608 0 0 1 0 Common Stock 2016-12-06 4 P 0 44174 16.3319 A 3674379 I Held by Alafi Capital Company, LLC Common Stock 2016-12-07 4 P 0 20826 16.1355 A 3695205 I Held by Alafi Capital Company, LLC The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.28 to $16.50 per share, inclusive. Mr. Alafi is a managing partner of Alafi Capital Company, LLC and may be deemed to beneficially own the shares held by Alafi Capital Company, LLC. Mr. Alafi disclaims beneficial ownership of the securities held by Alafi Capital Company, LLC except to the extent of his pecuniary interest therein. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.91 to $16.37 per share, inclusive. /s/ Lawrence J. Hineline, Attorney-in-fact 2016-12-07